Citi Cuts Docusign to Neutral With a $50 Target: Has the E-Signature Pioneer Lost Its Edge?

Citi has cut Docusign (NASDAQ:DOCU) shares to Neutral from Buy, setting a $50 price target that sits just above where the stock is currently trading. With Docusign stock down 36% year-to-date, the downgrade raises a fair question: has the e-signature pioneer lost its edge?

The timing is pointed. Docusign stock trades at $44, meaning Citi’s $50 target offers only modest upside from current levels. That’s a significant shift from a firm that previously held a Buy rating.

The Analyst’s Case

Docusign’s growth trajectory is stuck. Full-year fiscal 2026 revenue grew 8% year-over-year to $3.22 billion, and forward guidance points to roughly 8% growth again in fiscal 2027. That’s well below the double-digit threshold growth investors typically require from software companies.

Citi isn’t alone here. UBS cut its DOCU stock price target to $54, citing projected revenue deceleration to about 7% for full-year 2027, which is below Docusign’s own long-term target of over 10% growth. Bank of America initiated coverage of Docusign shares at Underperform with a $52 target, arguing the eSignature market is maturing and the company faces an uncertain growth trajectory.

Company Snapshot

Docusign pioneered electronic signatures and has expanded into its Intelligent Agreement Management platform, or IAM. The product suite includes Agreement Desk, AI-Assisted Review, and AI-powered eSignature tools. IAM customers now represent over $350 million in ARR, up from just 2% of total ARR a year ago to 11% today.

Docusign CEO Allan Thygesen has called it “the agreement system of action for companies of all sizes.” The business generated $1.06 billion in free cash flow for fiscal 2026, with the board authorizing an additional $2.0 billion in share repurchases, leaving roughly $2.6 billion remaining.

Why the Move Matters Now

Competitive pressure is intensifying. Adobe (NASDAQ:ADBE | ADBE Price Prediction) and Microsoft (NASDAQ:MSFT) both offer document and agreement capabilities embedded in platforms enterprises already use. Microsoft’s scale is particularly daunting, with $305 billion in trailing revenue and a 47% operating margin giving it resources to bundle signature tools at minimal cost. AI agent disruption poses a longer-term threat to standalone document workflow software as automation increasingly handles agreement processes end-to-end.

The valuation context adds nuance. Docusign’s trailing P/E ratio sits at 31x, while the forward P/E ratio drops sharply to 11x, suggesting the market already prices in limited near-term earnings growth. The consensus analyst price target across all Wall Street firms for DOCU stock stands at $62.89, well above Citi’s $50 mark, indicating that Citi is now among the more cautious voices on the street.

What It Means for Your Portfolio

For retirement-focused investors, Docusign’s strong free cash flow and buyback program provide some floor support. The IAM platform shows genuine early traction, and consistent EPS beats, including a $1.01 non-GAAP result against a $0.95 estimate in the most recent quarter, suggest solid execution. Yet Citi’s downgrade reflects a real concern: without a credible path to double-digit revenue growth, the stock’s re-rating potential is limited.

If you hold Docusign shares, the buyback program and margin expansion provide some cushion. If you’re considering a new position, you’d want to see IAM adoption accelerate meaningfully before building conviction.